Vertex's Pain Drug Trials and Challenges

This chapter explores Vertex's development of a non-opioid pain drug for acute pain and its recent disappointing trial results in chronic pain, particularly sciatica. It examines the hurdles the company faces in transitioning from rare diseases to a competitive pain management market while emphasizing the importance of reliable data in future studies.